The first edition of this book, published in 2009, was the only book of its kind dedicated exclusively to the diagnosis and management of pulmonary arterial hypertension (PAH) in patients with interstitial lung disease (ILD).

1. Radiographic Imaging in Interstitial Lung Disease and Pulmonary Hypertension.- 2. Invasive Techniques for Diagnosis of PH.- 3. Pathology of Vascular Changes In Interstitial Lung Diseases.- 4. Treatment of Pulmonary Hypertension in Interstitial Lung Disease.- 5. Lung Transplantation in Interstitial Lung Disease.- 6. Pulmonary Hypertension in Idiopathic Interstitial Pneumonias.- 7.  Sarcoidosis associated pulmonary hypertension: diagnosis and treatment.- 8. Hypersensitivity Pneumonitis.- 9. Interstitial Lung Disease Associated Pulmonary Hypertension in the Connective Tissue Disorders.- 10. Pulmonary Hypertension in Rare Parenchymal Lung Diseases.  

The first edition of this book, published in 2009, was the only book of its kind dedicated exclusively to the diagnosis and management of pulmonary arterial hypertension (PAH) in patients with interstitial lung disease (ILD). Over the past few years, new diagnostic tests and treatments of pulmonary arterial hypertension have been developed and tested. Diagnostic testing has led to more frequent and specific diagnosis in PAH patients, leading to the more widespread use of effective treatment and improved quality of life and reduction of mortality for PAH patients. Pulmonary Hypertension and Interstitial Lung Disease: A Clinical Guide, Second Edition provides an updated and expanded state-of-the-art overview of the problems seen by physicians in the clinical management of ILDs. The first section of the book discusses general features and includes an overview of clinical features, diagnosis and pathology of ILD. The second part discusses specific disorders such as idiopathic pulmonary fibrosis, sarcoidosis, and hypersensitivity pneumonia. Pulmonary  Hypertension and Interstitial Lung Disease, Second Edition is an invaluable resource for all physicians whose practice involves the care and treatment of patients with interstitial lung disease.

GPSR Compliance The European Union's (EU) General Product Safety Regulation (GPSR) is a set of rules that requires consumer products to be safe and our obligations to ensure this. If you have any concerns about our products you can contact us on ProductSafety@springernature.com. In case Publisher is established outside the EU, the EU authorized representative is: Springer Nature Customer Service Center GmbH Europaplatz 3 69115 Heidelberg, Germany ProductSafety@springernature.com